Editorial: Atrial fibrillation and circulating endothelial progenitor cells

Europace

Volumn 12, Issue 4, 2010, Pages 460-461

  Ravens, Ursula ^a  

^a DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOVASCULAR RISK; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; EDITORIAL; ENDOTHELIAL DYSFUNCTION; ENDOTHELIAL MICROPARTICLE; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; HEART ATRIUM FIBRILLATION; HUMAN; MORTALITY; PRIORITY JOURNAL; RECURRENT DISEASE; SINUS RHYTHM; STEM CELL; STROKE; TACHYCARDIA; THROMBOEMBOLISM; CYTOLOGY; HEMATOPOIETIC STEM CELL; NOTE; PATHOLOGY; RISK FACTOR; VASCULAR DISEASE;

BIOLOGICAL MARKER;

ATRIAL FIBRILLATION; BIOLOGICAL MARKERS; ENDOTHELIAL CELLS; HEMATOPOIETIC STEM CELLS; HUMANS; RECURRENCE; RISK FACTORS; VASCULAR DISEASES;

EID: 77950239046     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euq010     Document Type: Editorial

References (25)

1. Tsang TS, Miyasaka Y, Barnes ME, Gersh BJ. Epidemiological profile of atrial fibrillation: a contemporary perspective. Prog Cardiovasc Dis 2005;48:1-8.
2. Dobrev D. Atrial Ca2+ signaling in atrial fibrillation as an antiarrhythmic drug target. Naunyn Schmiedebergs Arch Pharmacol 2009; doi:10.1007/S00210-009- 0457-461 [E-Pub 26 September 2009].
3. Freestone B, Lip GY. The endothelium and atrial fibrillation. The prothrombotic state revisited. Haemostaseologie 2008;28:207-212
4. Guazzi M, Arena R. Endothelial dysfunction and pathophysiological correlates in atrial fibrillation. Heart 2009;95:102-106
5. Minamino T, Kitakaze M, Sanada S, Asanuama H, Kurotobi T, Koretsune Y et al. Increased expression of P-selectin on platelets is a risk factor for silent cerebral infarction in patients with atrial fibrillation: role of nitric oxide. Circulation 1998; 98:1721-1727
6. Akar JG, Jeske W, Wilber DJ. Acute onset human atrial fibrillation is associated with local cardiac platelet activation and endothelial dysfunction. J Am Coll Cardiol 2008;51:1790-1793
7. Skalidis EI, Zacharis EA, Tsetis DK, Pagonidis K, Chlouverakis G, Yarmenitis S et al. Endothelial cell function during atrial fibrillation and after restoration of sinus rhythm. Am J Cardiol 2007;99:1258-1262
8. Cai H, Li Z, Goette A, Mera F, Honeycutt C, Feterik K et al. Downregulation of endocardial nitric oxide synthase expression and nitric oxide production in atrial fibrillation: potential mechanisms for atrial thrombosis and stroke. Circulation 2002;106:2854-2858
9. Takahashi T, Kalka C, Masuda H, Chen D, Silver M, Kearney M et al. Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med 1999;5:434-438
10. Katoh H, Shimada T, Inoue S, Takahashi N, Shimizu H, Ohta Y et al. Reduced high serum hepatocyte growth factor levels after successful cardioversion in patients with atrial fibrillation. Clin Exp Pharmacol Physiol 2004;31:145-151
11. Li-Saw-Hee FL, Blann AD, Gurney D, Lip GY. Plasma von Willebrand factor, fibrinogen and soluble P-selectin levels in paroxysmal, persistent and permanent atrial fibrillation. Eur Heart J 2001;22:1741-1747
12. Pelosi E, Valtieri M, Coppola S, Botta R, Gabbianelli M, Lulli V et al. Identification of the hemangioblast in postnatal life. Blood 2002;100:3203-3208
13. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-967
14. Peichev M, Naiyer AJ, Pereira D, Zhu Z, Lane WJ, Williams M et al. Expression of VEGFR-2 and AC133 by circulating human CD34+ cells identifies a population of functional endothelial precursors. Blood 2000;95:952-958
15. Hill JM, Zalos G, Halcox JP, Schenke WH, Waclawiw MA, Quyyumi AA et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
16. Gill M, Dias S, Hattori K, Rivera ML, Hicklin D, Witte L et al. Vascular trauma induces rapid but transient mobilization of VEGFR+AC133+ endothelial precursor cells. Circ Res 2001;88:167-174
17. Aicher A, Zeiher AM, Dimmeler S. Mobilizing endothelial progenitor cells. Hypertension 2005;45:321-325
18. Shintani S, Murohara T, Ikeda H, Ueno T, Honma T, Katoh A et al. Mobilization of endothelial progenitor cells in patients with acute myocardial infarction. Circulation 2001;103:2776-2779
19. Massa M, Rosti V, Ferrario M, Campanelli R, Ramajoli I, Rosso R et al. Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction. Blood 2005;105:199-206.
20. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H et al. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999;18:3964-3972
21. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H et al. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors. Circ Res 2001;89:E1-E7.
22. Walter DH, Rittig K, Bahlmann FH, Kirchmair R, Silver M, Murayama T et al. Statin therapy accelerates reendothelialization: a novel effect involving mobilization and incorporation of bone marrow-derived endothelial progenitor cells. Circulation 2002;105:3017-3024
23. Siu C-W, Watson T, Lai W-H, Lee Y-K, Chan Y-H, Ng K-M et al. Relationship of circulating endothelial progenitor cells to the recurrence of atrial fibrillation after successful conversion and maintenance of sinus rhythm. Europace 2010;12: 517-521
24. Goette A, Jentsch-Ullrich K, Lendeckel U, Röcken C, Agbaria M, Auricchio A et al. Effect of atrial fibrillation on hematopoietic progenitor cells: a novel pathophysiological role of the atrial natriuretic peptide? Circulation 2003;108:2446-2449
25. Heiss C, Keymel S, Niesler U, Ziemann J, Kelm M, Kalka C. Impaired progenitor cell activity in age-related endothelial dysfunction. J Am Coll Cardiol 2005;45:1441-1448